688278.SSShanghai
Xiamen Amoytop Biotech Co., Ltd.
¥54.56
ListedJan 17, 2020
SectorHealthcare
IndustryBiotechnology
CountryChina
Employees3644
State-| CityXiamen| AddressNo. 330 Wengjiao Road| Phone86 59 2688 9106
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
22.9
?
Div. Rate
¥0.62
?
Div. Yield
1.10%
?
Payout Ratio
25.10%
?
Max Consec. Div. Years
6 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.85
?
Div. Growth Rate
100.00%
?
Score
75

Dividend History

Historical dividend payments by ex-dividend date.

May 29, 2026
¥ 0.6200
May 9, 2025
¥ 0.6200
May 23, 2024
¥ 0.4100
May 19, 2023
¥ 0.2130
May 24, 2022
¥ 0.1000
May 26, 2021
¥ 0.0500
Jun 4, 2020
¥ 0.0250

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!